
Please try another search
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine. In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.
Name | Age | Since | Title |
---|---|---|---|
Swapnil Purushotham Eaga | 38 | 2005 | Joint MD, CFO & Executive Director |
Purushotham Malaiah Eaga | 65 | 1989 | Founder, Executive Chairman & MD |
Smruthi Purushotham Eaga | 38 | 2022 | Non-Executive Non-Independent Director |
Dharmaraj Rao | 66 | 2024 | Independent Non-Executive Director |
Prakash Wadgaonkar | 64 | 2024 | Independent Non-Executive Director |
Anoop Anil Doshi | 42 | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review